As of Dec 15
| 0.00 / 0.00%|
The 23 analysts offering 12-month price forecasts for Amgen have a median target of 188.00, with a high estimate of 218.00 and a low estimate of 165.00. The median estimate represents a +6.19% increase from the last price of 177.04.
The current consensus among 26 polled investment analysts is to Hold stock in Amgen. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.